Validation of Aspiration Markers

Withdrawn before enrolling · Phase 1

Conditions studied: Pneumonia, Aspiration

In brief

This is an interventional crossover study aimed at validating diatom shells as a marker for cuff leak and microaspiration in mechanically ventilated, critically ill patients.

Key facts

Study ID

NCT02301845

Run by

Massachusetts General Hospital

People needed

0

Starts

2016-02-01

Expected to finish

2016-03-01

Last updated by the study team

2016-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years;
• Admission to Surgical ICUs (Ellison 4 or Blake 12);
• Patients expected to be intubated for at least 48 hours or longer from the time of enrollment.

You may not qualify if…

• High PEEP requirement at enrollment (PEEP higher than 8 cmH2O)
• Diagnosis of ARDS (any severity)
• Status asthmaticus
• Current or past participation in another interventional trial conflicting with the present study;
• Pregnant women;
• Prisoner status;
• Patients who had partial or total gastrectomy.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.